Atom Investors’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25M Buy
+19,115
New +$1.44M 0.07% 306
2026
Q2
– Sell
-12,162
Closed -$778K – 923
2026
Q1
$778K Buy
+12,162
New +$844K 0.06% 402
2025
Q2
– Sell
-22,561
Closed -$1.12M – 697
2025
Q1
$1.12M Buy
+22,561
New +$1.25M 0.14% 199
2021
Q4
– Sell
-3,426
Closed -$415K – 340
2021
Q3
$415K Buy
+3,426
New +$468K 0.03% 216

Other funds holding IRON

Atom Investors's IRON Position: Q3 2026 in Review

Atom Investors opened a new position in Disc Medicine (IRON) in Q3 2026: 19,115 shares worth $1.25M. The stake represents 0.07% of the portfolio and ranks #306 among its holdings. This is a return to the name: Atom Investors previously reported a position in IRON as recently as Q1 2026.

Atom Investors first reported a position in IRON in Q3 2021 and has held it in 4 quarters since. 236 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • Atom Investors held 19,115 shares of Disc Medicine worth $1.25M as of Q3 2026.
  • Disc Medicine was a new Atom Investors position in Q3 2026.
  • Disc Medicine made up 0.07% of Atom Investors's portfolio in Q3 2026, its #306 holding.
  • Atom Investors first reported a position in Disc Medicine in Q3 2021 and has held it in 4 quarters since.
  • 236 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.